Tag - VLRX

Markets

BTIG cuts Valeritas Holdings to neutral; removes PT

BTIG downgraded Valeritas Holdings (NASDAQ:VLRX) to “neutral” from “buy” and removed its previous $10 price target after the company reduced its fourth quarter revenue guidance due to a temporary supply disruption and...

December 23, 2019

Developments

Valeritas V-Go achieves reduced A1c and daily insulin usage

Type 2 diabetes (T2D) patients achieved significantly lower average A1c levels and daily insulin usage when switching to Valeritas Holdings‘ (NASDAQ:VLRX) V-Go wearable insulin delivery device. A retrospective...

November 15, 2019

Developments

Valeritas V-Go reports greater A1C reduction with 24% less daily insulin

Valeritas Holdings’ (NASDAQ:VLRX) V-Go wearable insulin delivery device significantly lowered Type 2 diabetes (T2D) patients’ average A1C levels, compared with those using standard insulin treatment. Valeritas’ V-GoAL...

April 8, 2019

Tag - VLRX

BTIG cuts Valeritas Holdings to neutral; removes PT

Valeritas V-Go achieves reduced A1c and daily insulin usage

Valeritas V-Go reports greater A1C reduction with 24% less daily insulin

General

More